GenNx360 Capital Partners Acquires Majority Stake in Tensentric

Industrial Growth Partners Acquires SENS

March 10, 2025

Manufacturing

Industrial Growth Partners (IGP) has acquired SENS Holdings, LLC, a Longmont, Colorado-based designer and manufacturer of battery chargers, integrated power systems and battery monitoring solutions. IGP partnered with SENS management and rollover equity to create a platform to accelerate growth, scale operations and expand the company’s presence across critical-infrastructure end markets such as data centers, hospitals and utilities.

GenNx360 Capital Partners Invests in Nutra-Med Packaging, Inc.

February 4, 2022

Packaging

GenNx360 Capital Partners has made a platform investment in Nutra-Med Packaging, a Whippany, New Jersey-based contract packaging company serving the pharmaceutical, health & wellness and medical devices markets. The investment will support Nutra-Med's next phase of accelerated growth; founder Mahesh Gupta will move to an advisory role and Kunal Gupta will lead the company as CEO.

TPG Capital Acquires Majority Stake in Confluent Medical

January 5, 2022

Medical Devices

TPG Capital has made a majority investment in Confluent Medical Technologies, a materials-science-led developer and manufacturer of complex implantable medical devices and delivery systems. Existing investor Ampersand Capital Partners retains a substantial minority stake; the investment will provide capital and expertise to expand Confluent's manufacturing capabilities and support growth into new technical areas and end markets.

Great Point Partners Completes Growth Recapitalization of Velentium

September 29, 2021

Medical Devices

Great Point Partners completed a growth recapitalization of Houston-based Velentium, a professional engineering and contract medical device manufacturer. The investment will fund Velentium's expansion initiatives — including tuck-in acquisitions and enhanced engineering and manufacturing capabilities — while preserving the company's quality and culture.

Ampersand Capital Partners Invests in Genezen Laboratories

January 5, 2021

Biotechnology

Ampersand Capital Partners has made a majority growth-equity investment in Genezen Laboratories, a cell and gene therapy CDMO, to fund completion of a 25,000 sq. ft. cGMP lentiviral vector production facility and expand process development and analytical testing capabilities. The capital will support Genezen's capability expansion across upstream/downstream processing, analytical testing, and cGMP vector production to serve early‑phase and growth-stage cell and gene therapy developers.

Gener8 Acquires Symbient Product Development

February 25, 2020

Medical Devices

Gener8 LLC, a portfolio company of Sverica Capital Management, has acquired Symbient Product Development, a Carlsbad, California-based designer and low-to-medium volume manufacturer of polymer life-sciences consumables. The deal expands Gener8's capabilities beyond advanced instrumentation to provide turnkey instrument-and-consumable solutions for point-of-care diagnostics and drug delivery markets.